Platinum versus non‐platinum chemotherapy regimens for small cell lung cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Platinum Versus Non‐platinum Chemotherapy Regimens for Small Cell Lung Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437089/1/Platinum_versus_non‐platinum_chemotherapy_regimens_for_small_cell_lung_cancer.
Platinum versus non‐platinum chemotherapy regimens for small cell lung cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437089/1/Platinum_versus_non‐platinum_chemotherapy_regimens_for_small_cell_lung_cancer. Accessed December 3, 2024.
Platinum versus non‐platinum chemotherapy regimens for small cell lung cancer. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437089/1/Platinum_versus_non‐platinum_chemotherapy_regimens_for_small_cell_lung_cancer
Platinum Versus Non‐platinum Chemotherapy Regimens for Small Cell Lung Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437089/1/Platinum_versus_non‐platinum_chemotherapy_regimens_for_small_cell_lung_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Platinum versus non‐platinum chemotherapy regimens for small cell lung cancer
ID - 437089
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437089/1/Platinum_versus_non‐platinum_chemotherapy_regimens_for_small_cell_lung_cancer
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -